| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.78 | 0.003 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 6e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |